Video Experimental Relacionado
Updated: Jul 19, 2026
11:01
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
Inhibidores específicos de alelos de las proteínas tirosina fosfatasas
Hillary E Hoffman1, Elizabeth R Blair, James E Johndrow
1Department of Chemistry, Amherst College, Amherst, Massachusetts 01002, USA.
Journal of the American Chemical Society
|March 3, 2005
Resumen
Los investigadores diseñaron las fosfatasas de proteína tirosina (PTP) para ser inhibidas selectivamente. Esta estrategia crea nuevos inhibidores de PTP para el estudio de las vías de señalización celular.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Enzimología Enzimología.
Sus antecedentes:
- Las fosfatasas de proteína tirosina (PTP) son reguladores cruciales de las vías de señalización celular.
- El desarrollo de inhibidores selectivos de la PTP es un desafío debido a las arquitecturas de sitio activo conservadas.
- La inhibición dirigida de la PTP es esencial para diseccionar redes complejas de fosforilación.
Objetivo del estudio:
- Diseñar una interfaz PTP / inhibidor para lograr la selectividad del objetivo.
- Para crear mutantes PTP "sensibilizados al inhibidor" utilizando mutagenesis dirigida al sitio.
- Identificar nuevos inhibidores que se dirigen selectivamente a las PTP modificadas.
Principales métodos:
- La mutagenesis dirigida al sitio se empleó en la enzima PTP1B.
- Un inhibidor PTP de amplia especificidad fue modificado químicamente.
- Los inhibidores modificados se examinaron contra el tipo silvestre y el PTP1B mutante.
Principales resultados:
- Se generaron mutantes de Ile219Ala PTP1B y mostraron sensibilidad a los inhibidores modificados.
- Se logró la inhibición selectiva de Ile219Ala PTP1B sobre el PTP1B de tipo silvestre.
- La mutación Ile219Ala confirió sensibilidad del inhibidor a la PTP de células T, lo que indica una aplicabilidad más amplia.
Conclusiones:
- El rediseño de la interfaz PTP / inhibidor es una estrategia viable para el desarrollo de inhibidores selectivos de PTP.
- Una sola mutación puntual puede crear diversas variantes de PTP sensibles a los inhibidores.
- Este enfoque ofrece una ruta prometedora para generar herramientas para estudiar la función de PTP en la señalización celular.
Videos de Conceptos Relacionados
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...